Advertisement

Topics

Bonanza of New Options for HR+/HER2- Breast Cancer

09:56 EDT 19 Oct 2016 | Medscape

Patients with advanced HR-positive/HER2-negative breast cancer may benefit from practice-changing treatment options, as reported by Dr Javier Cortés from ESMO 2016.
Medscape Oncology

Original Article: Bonanza of New Options for HR+/HER2- Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Bonanza of New Options for HR+/HER2- Breast Cancer"

Quick Search
Advertisement
 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...